This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2019
EAU 2019
Prostate Cancer
Bladder Cancer
Kidney Cancer
UTUC
Endourology
Testicular and Penile Cancer
EAU 2019 Prostate Cancer
Viewing 41-60 of 79 articles
EAU 2019: Pivotal Study of MRI-Guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer: Preliminary Results
EAU 2019: Multiparametric Magnetic Resonance of the Prostate During Active Surveillance for Low-Risk Prostate Cancer: Time to Reduce the Number of Follow-up Biopsies?
EAU 2019: How Does Burnout Affect Patient Outcome?
EAU 2019: Discussion on the ARAMIS Study - Darolutamide in Non Metastatic Castration-Resistant Prostate Cancer
EAU 2019: Potentials of 68Ga-Prostate Specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer
EAU 2019: Darolutamide Elicits a Strong PSA Response in Men with nmCRPC: Results from the ARAMIS Study
EAU 2019: Recent Advances in Prostate Cancer: Real Game Changers? Multi-parametric Prostate MRI
EAU 2019: Which Cancers Are Still Diagnosed by Standard Prostate Biopsy without an Upfront Multiparametric MRI?
EAU 2019: Genetic Testing for Hereditary Prostate Cancer Among Men in Israel
EAU 2019: Debate: Is MRI-Targeted Biopsy Enough?
EAU 2019: Is One Targeted Biopsy Core of the Index Lesion Sufficient to Accurately Detect Clinically Significant Prostate Cancer Across all PI-RADS Scores?
EAU 2019: Case Based Debate: Additional Local Therapy Versus Systemic Therapy for Clinically Node Positive Prostate Cancer
EAU 2019: Checkpoint Inhibitors – Safety and Management in Daily Practice
EAU 2019: Comparison Between Limited and Extended Lymph Node Dissection for Prostate Cancer: Results from a Large Clinically Integrated Randomized Trial
EAU 2019: Development and External Validation of a Novel Risk Score to Predict Long-Term Clinical Recurrence After Radical Prostatectomy
EAU 2019: Discussion: Fast Bi-Parametric MRI vs Multi-Parametric MRI and TRUS-Biopsy for Detecting Clinically Significant Prostate Cancer
EAU 2019: The Role of (fast) Bi-Parametric MRI versus Multi-Parametric MRI and TRUS-biopsy for Detecting Clinically Significant Prostate Cancer in Biopsy Naïve Men with Elevated PSA
EAU 2019: Clinical Impact of Male BRCA2 Germline Pathogenic Mutation: Preliminary Results from a National Clinical Research Hospital
EAU 2019: The Urologist’s Perspective on Active Surveillance
EAU 2019: Assessing the Diagnostic Accuracy of Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer: Results from a Single-Institutional Experience
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free